Company: LIMN
Filing Date: 2025-01-27
Form Type: POS AM
Source: 0001104659-25-006325
Chunk: 450

Company: Liminatus Pharma, Inc.
Filing Date: 2025-01-27
Form: POS AM
Chunk 450
---
 equivalents held in Trust          | ​ | ​ | ​                   | ​ | 4,291,332 | ​ | ​ | ​ | ​       | ​ | 4,291,332 | ​ | ​ | ​ | ​       | ​ | — | ​ | ​ | ​ | ​       | ​ |       — | ​ | ​ |
| Liabilities:                            | ​ | ​ | ​                   | ​ |         ​ | ​ | ​ | ​ | ​       | ​ |         ​ | ​ | ​ | ​ | ​       | ​ | ​ | ​ | ​ | ​ | ​       | ​ |       ​ | ​ | ​ |
| Public Warrants                         | ​ | ​ | ​                   | ​ |   207,690 | ​ | ​ | ​ | ​       | ​ |   207,690 | ​ | ​ | ​ | ​       | ​ | — | ​ | ​ | ​ | ​       | ​ |       — | ​ | ​ |
| Private Warrants                        | ​ | ​ | ​                   | ​ |   168,754 | ​ | ​ | ​ | ​       | ​ |         — | ​ | ​ | ​ | ​       | ​ | — | ​ | ​ | ​ | ​       | ​ | 168,754 | ​ | ​ |
| Derivative liability                    | ​ | ​ | ​                   | $ |     2,202 | ​ | ​ | ​ | ​       | $ |         — | ​ | ​ | ​ | ​       | $ | — | ​ | ​ | ​ | ​       | $ |   2,202 | ​ | ​ |

Measurement — The Company established the initial fair value for the warrants on March 9, 2021, the date of the consummation of the IPO. On September 30, 2024 and December 31, 2023, the fair value was

F-24

TABLE OF CONTENTS

IRIS ACQUISITION CORP NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS remeasured. In May 2021, the Public Warrants were separately traded in the open market and the valuation for the Public Warrants was based on unadjusted quoted prices at September 30, 2024 and December 31, 2023. For September 30, 2024 and December 31, 2023, the Company used a Monte Carlo simulation model to value the Private Placement Warrants. The